der Funktion von Aktinregulatoren in der Tumorgenese von zentraler Bedeutung.
In der vorliegenden Arbeit konnte ich das Aktin-quervernetzende Protein (Brumby and Richardson, 2003; Pagliarini and Xu, 2003 (Brumby and Richardson, 2003; Pagliarini and Xu, 2003) , results in the formation of invasive tumors. These clonal tumors recapitulate several hallmarks of human cancer. I show that Cher is highly up-regulated in these invasive ras V12 scrib 1 tumors on the mRNA and protein level. Further, I provide evidence that cher expression is regulated in a Jun N-terminal kinase (JNK) and Fos-dependent manner and identify cher as a direct target of JNK signaling.
Although non-essential in the normal EAD epithelium, Cher becomes required in the tumor cells for their growth and invasiveness. When deprived of Cher (cher 1 ), these tumor clones lose their full potential to proliferate and breach tissue boundaries. Reduced invasiveness and restored photoreceptor differentiation of ras V12 scrib 1 cher 1 tumors improve survival of tumor bearing animals, resulting in emergence of several adults. Loss of cher affects the morphology of clonal tumors, with a major impact on clones generated in the apical peripodial epithelium (PE) of the EAD, which are frequently extruded and stay confined between the PE and the underlying columnar epithelium (CE). Therefore, the intact PE presents a mechanical barrier to tumor cell expansion, which only those tumors large enough can overcome. I identify nonmuscle myosin II (MyoII) heavy chain subunit Zipper (Zip) as novel interaction partner of Cher. Through binding to Zip, Cher likely strengthens the cortical actomyosin network and reinforce mechanical tension within the invasive tumor, as Cher positively affects MyoII activity. Further, in ras V12 scrib 1 tumors Cher is necessary for deregulation of Hippo (Hpo)/Yki signaling independent of the JNK pathway, suggesting a possible link between Cher-dependent mechanical tension and attenuation of Hpo signaling in the tumor context. My preliminary data also Abstract suggest that similar to mammalian cancer cells, malignant ras V12 scrib 1 tumors reprogram cellular metabolism towards aerobic glycolysis, boosting glycolytic flux, a process which requires JNK and Cher function.
In summary, this study identifies Cher as a new target of JNK signaling that links cytoskeleton dynamics to tumor progression.
